InsidersTradesSigma
Track the 우정바이오 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 우정바이오 has logged 4 insider filings. Market capitalisation: €37.9bn. The latest transaction was filed on 23 June 2026 (Other). Among the most active insiders: 우정바이오. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
우정바이오 is a company in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in the development of biopharmaceutical products.